NIH-funded research NIH-funded research

Long‑lasting antibody vaginal ring for non‑hormonal birth control

Official title: Development of an ultrapotent anti-sperm antibody construct for non-hormonal contraception

Funded at Mucommune, LLC · NIH-11478956 · Data updated 2026-11-12

Testing a vaginal ring that slowly releases an antibody to trap sperm and prevent pregnancy for people seeking non‑hormonal contraception.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMucommune, LLC
NIH-funded
Lab location1 site (Morrisville, UNITED STATES)
Project startMarch 25, 2025
Project endFebruary 28, 2029
Funding year2026
Award (this year)$575,000
NIH project number4R33HD117428-02
Project IDNIH-11478956 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are people of reproductive age who want effective non‑hormonal birth control and are willing and able to use an intravaginal device.

Less likely to help

This approach would not benefit men, people past reproductive age, or those who cannot or prefer not to use intravaginal products or who need protection against sexually transmitted infections.

What this research studies

You would use a small intravaginal ring that releases a specially designed anti‑sperm antibody over time to clump and trap sperm in mucus so they cannot reach an egg. The team has previously tested related antibodies in early human work and in animal models and is advancing a more potent multimeric antibody (FFIFF) that worked very well in sheep. This project aims to pair that antibody with a capsule‑IVR device that can steadily release the antibody for sustained, user‑controlled contraception. The work combines lab development, formulation of the ring, and preclinical/early clinical steps toward a long‑acting non‑hormonal option.

Why it matters

Potential benefit: If successful, this could offer a long‑acting, user‑controlled contraceptive option that avoids systemic hormones.

How similar studies have gone: Early exploratory human studies with a related anti‑sperm antibody and strong results in sheep models showed promising sperm elimination, but a sustained‑release vaginal ring is a newer, less tested application.

Where this research is happening

  • Mucommune, LLC
    Morrisville, United States
    Active

Researchers

  • Principal investigator: Kushiro, Keiichiro — Mucommune, LLC
  • Study coordinator: Kushiro, Keiichiro

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.